These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31764946)

  • 1. Implementation Strategies for Cardiovascular Polypills.
    Huffman MD; Salam A; Patel A
    JAMA; 2019 Dec; 322(23):2279-2280. PubMed ID: 31764946
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Disease Prevention at a Crossroads:: Precision Medicine or Polypill?
    Joyner MJ; Paneth N
    JAMA; 2019 Dec; 322(23):2281-2282. PubMed ID: 31764938
    [No Abstract]   [Full Text] [Related]  

  • 3. A polypill is the solution to the pharmacological management of cardiovascular risk: no.
    Toop L
    J Prim Health Care; 2009 Sep; 1(3):234-6. PubMed ID: 21534329
    [No Abstract]   [Full Text] [Related]  

  • 4. A polypill is the solution to the pharmacological management of cardiovascular risk: yes.
    Elley CR
    J Prim Health Care; 2009 Sep; 1(3):232-4. PubMed ID: 20690388
    [No Abstract]   [Full Text] [Related]  

  • 5. The dream of a do-it-all "polypill". The reality: patients will probably keep taking separate heart drugs.
    Heart Advis; 2003 Oct; 6(10):1, 7. PubMed ID: 15106540
    [No Abstract]   [Full Text] [Related]  

  • 6. Fixed-dose combination therapy (polypill) for the prevention of cardiovascular disease.
    Huffman MD; de Cates AN; Ebrahim S
    JAMA; 2014 Nov; 312(19):2030-1. PubMed ID: 25399279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What would you do?].
    Hedlund K
    Lakartidningen; 2005 May 2-15; 102(18-19):1467-8; author reply 1468. PubMed ID: 15929438
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular medications.
    Williams S; Wynn G; Cozza K; Sandson NB
    Psychosomatics; 2007; 48(6):537-47. PubMed ID: 18071104
    [No Abstract]   [Full Text] [Related]  

  • 9. [The Polypill - A Practicable Approach?].
    Thürmann PA; Kleinerüschkamp AG; Boehme P
    Dtsch Med Wochenschr; 2019 Jun; 144(11):715-718. PubMed ID: 31163467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
    Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One pill, four questions: what we still need to know about reducing cardiovascular risk with combination therapy.
    Hughes AD
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):ED000079. PubMed ID: 24818243
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of polypill difficult to demonstrate from varied studies, say Cochrane reviewers.
    Torjesen I
    BMJ; 2014 Apr; 348():g2819. PubMed ID: 24742603
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose Combination Medication (Polypills) in Andhra Pradesh, India: A Mixed-Methods Study.
    Salam A; Praveen D; Patel A; Tewari A; Webster R
    Glob Heart; 2019 Sep; 14(3):303-310. PubMed ID: 31451238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular agents can prevent type 2 diabetes].
    Nilsson P
    Lakartidningen; 2003 Feb; 100(7):528-30. PubMed ID: 12640987
    [No Abstract]   [Full Text] [Related]  

  • 15. Polypills for the prevention of Cardiovascular diseases.
    Kolte D; Aronow WS; Banach M
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1255-1264. PubMed ID: 27645895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention: Polypills for cardiovascular prevention: a step forward?
    Sanz G; Fuster V
    Nat Rev Cardiol; 2013 Dec; 10(12):683-4. PubMed ID: 24101102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
    Cowie MR
    Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiovascular polypill in high-risk patients.
    Lafeber M; Spiering W; Singh K; Guggilla RK; Patil V; Webster R;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1234-42. PubMed ID: 22019908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases.
    Webster R; Murphy A; Bygrave H; Ansbro É; Grobbee DE; Perel P
    Glob Heart; 2020 Aug; 15(1):57. PubMed ID: 32923350
    [No Abstract]   [Full Text] [Related]  

  • 20. Uses of polypills for cardiovascular disease and evidence to date.
    Huffman MD; Xavier D; Perel P
    Lancet; 2017 Mar; 389(10073):1055-1065. PubMed ID: 28290995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.